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Characterization of a Synaptic
Vesicle Binding Motif on the Distal
CaV2.2 Channel C-terminal
Sabiha R. Gardezi, Arup R. Nath, Qi Li and Elise F. Stanley*
Laboratory of Synaptic Transmission, Krembil Research Institute, Toronto, ON, Canada
Neurotransmitter is released from synaptic vesicles (SVs) that are gated to fuse with
the presynaptic membrane by calcium ions that enter through voltage-gated calcium
channels (CaVs). There is compelling evidence that SVs associate closely with the
CaVs but the molecular linking mechanisms remain poorly understood. Using a cell-
free, synaptic vesicle-pull-down assay method (SV-PD) we have recently demonstrated
that SVs can bind both to the intact CaV2.2 channel and also to a fusion protein
comprising the distal third, C3 segment, of its long C-terminal. This site was localized
to a 49 amino acid region just proximal to the C-terminal tip. To further restrict the
SV binding site we generated five, 10 amino acid mimetic blocking peptides spanning
this region. Of these, HQARRVPNGY effectively inhibited SV-PD and also inhibited SV
recycling when cryoloaded into chick brain nerve terminals (synaptosomes). Further,
SV-PD was markedly reduced using a C3 fusion protein that lacked the HQARRVPNGY
sequence, C3HQless. We zeroed in on the SV binding motif within HQARRVPNGY by
means of a palette of mutant blocking peptides. To our surprise, peptides that lacked
the highly conserved VPNGY sequence still blocked SV-PD. However, substitution of
the HQ and RR amino acids markedly reduced block. Of these, the RR pair was
essential but not sufficient as the full block was not observed without H suggesting a
CaV2.2 SV binding motif of HxxRR. Interestingly, CaV2.1, the other primary presynaptic
calcium channel, exhibits a similar motif, RHxRR, that likely serves the same function.
Bioinformatic analysis showed that variations of this binding motif, +(+) xRR (where +
is a positively charged aa H or R), are conserved from lung-fish to man. Further studies
will be necessary to identify the C terminal motif binding partner on the SV itself and to
determine the role of this molecular interaction in synaptic transmission. We hypothesize
that the distal C-terminal participates in the capture of the SVs from the cytoplasm,
initiating their delivery to the active zone where additional tethering interactions secure
the vesicle within range of the CaV single Ca2+ domains.
Keywords: presynaptic, calcium channel, synaptic vesicle, tether, SV-PD, CaV2.2, transmitter release, C-terminal,
binding motif
INTRODUCTION
Calcium ion entry through presynaptic voltage-sensitive CaV2.2 calcium channels is known to gate
transmitter release by the fusion and discharge of transmitter from docked synaptic vesicles (SVs)
(Stanley, 2016). The finding that SV fusion can be gated by a single CaV2.2 led to the prediction that
the channel and SV are linked by at least one protein tether (Stanley, 1993) and a number of studies
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have explored this molecular interaction. Two main molecular
tethering linkage mechanisms have been considered; first, a link
involving integral surface membrane proteins, in particular the
SNARE protein syntaxin 1 (Sheng et al., 1998; Seagar et al., 1999;
Mochida et al., 2003) and a surface membrane-independent,
cytoplasmic link from the channel directly to the SV (Kaeser
et al., 2011; Wong et al., 2013, 2014). A novel, cell-free synaptic
vesicle-pull down assay (SV-PD) demonstrated for the first
time that SVs can bind to CaV2.2 by a direct, membrane-
independent mechanism (Wong et al., 2013). This study also
showed that intact SVs can be captured by a synthetic fusion
protein comprising the distal third (C3) of the CaV2.2 channel
C-terminal (Wong et al., 2013). A later study used truncated
or PDZ ligand domain-modified C3 constructs and mimetic
blocking peptides to identify a 49 amino acid residue (aa) SV
binding region, 9 aa proximal to the C-terminal distal tip (Wong
et al., 2014), as indicated in Figure 1.
In this study we used mimetic blocking peptides that span
the SV binding region to search for specific SV attachment
motifs. We then tested if these peptides would interfere with
SV-PD by blocking the (unknown) SV binding site. In a
complimentary study we also to tested if the peptides affected
presynaptic SV recycling in functional isolated brain nerve
terminals (synaptosomes, SSMs) using a ‘peptide cryoloading’
method combined with a styryl dye SV recycling assay (Nath
et al., 2014). Finally, we used a combination of bioinformatics
analysis comparing release site-associated CaV types in a range
of species together with mutated peptide blockers to identify a
putative SV binding motif.
MATERIALS AND METHODS
Synaptic Vesicle Binding Assays
Synaptosome and Synaptic Vesicle Fractionation
The synaptosome and SV fractionation method has been
described in detail (Wong et al., 2013). Briefly, E14–E17 chick
brains (typically 100 per preparation) were homogenized and
the SVs purified by differential and sucrose density gradient
centrifugation. The SVs were maintained intact in detergent-
free buffer for all experiments. Key buffers were: homogenization
buffer (HB), 0.32 M sucrose, 10 mM HEPES, 2 mM EDTA, pH
7.4; and HEPES-lysis buffer, 50 mM HEPES, 2 mM EDTA, pH 7.4
(Wong et al., 2013, 2014).
Antibodies
Antibodies used in the present study are listed in Table 1.
Western Blot
Standard Western blotting (WB) method was carried out as
described (Wong et al., 2013, 2014) except immunoblots were
imaged using a ChemiDocTM XRS System (Bio-Rad).
Protein Detection
Mini-PROTEAN TGX ‘Stain-Free’ Precast Gels (4–15%,
Bio-Rad) were used to C3WildF and C3HQless fusion protein
dilution analysis. The samples were separated using SDS-PAGE
as previously described (Wong et al., 2013, 2014). The gels were
than UV activated according to the manufacturer’s protocol
using the ChemiDoc XRS. The fusion protein bands were
visualized within 0.5 s after gel activation.
Synaptic Vesicle Pull-Down Assay
The SV-PD assay has been described in detail (Wong et al., 2013,
2014). Briefly, purified SVs were incubated with immobilized C3
fusion proteins or GST control in a detergent free, SV-PD buffer
(HB with 5 mM EGTA and free Ca2+ clamped to 10 nM, CaCl2
was calculated using MaxChelator). Prior to SV-PD, 40 µl of the
SV suspension, containing the SV sample used for pull-down
assays, was reserved for WB. SV-PD samples were washed four
times with SV-PD buffer and solubilized in 4X Laemmli sample
buffer with 5% β-mercaptoethanol for WB. Immunoblots were
probed for integral SV membrane proteins as markers for vesicle
capture. SV-PD was considered positive if the band intensity of
two of the vesicle integral membrane marker proteins, generally
SV2 and STG, were more intense than for control samples (Wong
et al., 2013, 2014). The use of freshly prepared SVs and detergent-
free buffers makes these both time-demanding experiments with
some non-specific SV capture with control beads and fusion
proteins (Wong et al., 2014). Criteria for acceptance for further
analysis were stringent based on a rejection of blots with a
significant level of non-specific binding to controls.
CaV2.2 Distal C-terminal Region Mimetic
Peptides
Control and putative blocking peptides were synthesized at the
SPARC BioCentre (Toronto, ON). Control peptides for this study
have been described (Wong et al., 2014): RQLPQTPL (SH3,
aa 2210–2217), HEADEDDWC (aa 2349–2357), and HEADE
(aa 2349–2353). Five peptides spanning the SV binding site
region were: ATNSGRSSRT (aa 2299–2308), SYVSSLTSQS (aa
2309–2318), HQARRVPNGY (aa 2319–2328), HYTLGLNTGP
(aa 2329–2338), and GTGTRGRSYY (aa 2339–2348; Figure 1A).
Peptides were reconstituted in HB at 10 mM. SVs were incubated
with the peptides for 2 h at 4◦C prior to pull-down with the
fusion proteins. To establish a suitable peptide concentration,
we carried out SV-PD trials using C3WildF in the presence
of HQARRVPNGY, which was shown to block in preliminary
experiments (Figure 1B). To avoid complications due to
variations in total soluble peptide we included a control peptide,
SH3, or HEADE, to maintain the total peptide concentration
at 1.2 mM. Previous experiments demonstrated that neither
of these inhibit SV-PD (Wong et al., 2013). In a preliminary
experiment we found that 50% maximal inhibition of SV-
PD was observed at ∼0.3 mM, as assessed by SV2 recovery,
with both control peptides (SH3, Figure 1C; HEADE Data
not shown) and we therefore used a 0.6 mM peptide for all
blocking experiments, except as stated. During the course of
these experiments we noted that one of the control peptides,
HEADE, a sequence within the C-terminal distal to our primary
area of interest, actually enhances SV-PD (Figures 2 and 3). This
effect was not observed with the SH3 or HEADEDDWC – a
C-terminal tip peptide that includes HEADE (Figure 3). Thus,
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FIGURE 1 | (A) Diagram of the full-length C3 fusion proteins used in this study with the synaptic vesicle (SV) binding site and the synthetic mimetic peptides.
GST-tagged fusion proteins, C3WildF and C3GST, comprising approximately the distal third of the CaV2.2 C-terminal, are indicated by the horizontal dashed lines. The
two fusion proteins are identical except for a FLAG tag on the distal tip of the former. The 49 aa sequence of the SV binding region is indicated together with the 9 aa
(HEADEDDWC) channel terminus. The colored boxes define the five mimetic blocking peptides synthesized to identify the SV binding motif. The location of the
HEADE peptide sequence is also indicated within the HEADEDDWC region (empty box). (B) Preliminary experiment showing inhibition of SV-PD by a mimetic
peptide. Sucrose gradient-purified SV samples in a detergent-free buffer were pre-incubated with test HQARRVPNGY or HYTLGLNTGP peptides (1.2 mM) prior to
SV-PD with immobilized C3WildF fusion protein. SV capture was assessed by Western blotting (WB) for the recovery of at least two integral SV proteins: SV2 and
STG. SV-PD was considerably less with HQARRVPNGY in comparison to HYTLGLNTGP. Equal loading of the fusion protein was confirmed using an anti-GST tag
antibody. (C) Optimization of peptide concentration for detection of SV-PD block. Based on preliminary experiments, HQARRVPNGY (HQAR) was used to test for a
suitable peptide concentration for effective block. SVs were pre-incubated with HQARRVPNGY peptide with a control peptide, SH3 (which was used as the control
in all experiments, unless indicated), added in reciprocal amounts to maintain a total buffer peptide concentration of 1.2 mM (N = 1). SV-PD was carried out as
described and SV capture was assayed by blot for SV2 or STG (not shown). Note the decline in SV2 recovery, corresponding to the reduction in SV capture, at
HQARRVPNGY concentrations greater than 0.03 mM.
while this finding is of interest in itself, the latter makes it
less likely that enhancement in SV-PD observed with HEADE
is of biological significance. Nonetheless, after this finding
we stopped using HEADE as a control in the peptide-block
experiments.
We also generated a series of blocking peptides to zero
in on the C3 region SV binding motif. These peptides were:
HQARRAPNGA, HQARRGPNGG, HQARRAGGGA, HQARR
GAAAG, HQARRAAAAA, HQAAAVPNGY, HQAGGAGGGA,
AAARRVPNGY, and GGARRAGGGA (see below).
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TABLE 1 | Antibodies.
Antibody Target Source (WB dilution) WB dilution
FLAG (m) FLAG tag Sigma–Aldrich 1:4000
GST (m) GST tag Santa Cruz Biotechnology 1:4000
L4569 (p) C-terminal of CaV2.2 long splice variant Stanley lab (Khanna et al., 2006) 1:1000
RIM2 (RIM1/2; p) RIM (RIM1 and 2; RIM1/2)∗ Synaptic Systems, GMBH 1:2000
SV2A (m) SV2A (SV2) Synaptic Systems, GMBH (clone 171G0) 1:1000
Synaptotagmin (m) Synaptotagmin-1 (STG) Abcam (clone ASV30) 1:1000
VAMP (p) Vesicle Associated Membrane Protein 1,2,3 (VAMP) Synaptic Systems, GMBH 1:2000
V-ATPase (p) V-ATPase (V0) A1 Santa Cruz Biotechnology 1:1000
∗RIM2 antibody has been characterized previously. See Wong and Stanley (2010).
Immunoblot Quantification and Analysis
Immunoblots were probed for integral vesicle proteins, SV2,
and STG, which were used as markers for SV capture in
this study. Immunoblots were imaged with the ChemiDoc
(Bio-Rad) with a broad range of exposure times. For each
experiment, protein band intensities were quantified by
densitometry using Image Lab (Bio-Rad) software from a
common blot at a single exposure selected for clear bands
without saturation. Background counts were subtracted using
an automated routine and protein band intensities of test (Ix)
or control (Ic) peptide treatments were measured. Percent
integral protein capture, and hence %SV-PD, was calculated as:
(Ix/Ic)× 100.
All experiments were pre-hoc testing treated samples to a
defined control. Data are presented as mean +SE (%) and
“N-value” represents the number of independent experiments.
Statistical analysis was performed with GraphPad Prism 6.0. Each
peptide treatment was tested using a one sample, two-tailed
t-test based on the null hypothesis that mean SV-PD = 100%
(that is equal to the control peptide), as described (Wong
et al., 2013). Data was also tested with a post hoc ANOVA
adjusted with a Bonferroni–Holms correction for multiple
comparisons1. Values were considered significantly different if
p< 0.05.
Functional Assay of Synaptic Vesicle
Recycling
Cryoloading
The method has been described (Nath et al., 2014). Briefly, SSMs
were isolated as described above. SSMs were pelleted in SET
buffer (0.32 M sucrose; 1 mM EDTA; 5 mM Tris) in preparation
for cryoloading. 1.2 mM of the blinded mimetic peptide (or
equivalent control) was added to the SSM mixture (50 µL total
volume) with 20 µM of the 3 kD Dextran-FITC loading maker
and was frozen slowly in a –80◦ freezer.
Styryl Dye Uptake
Vesicle turnover was assessed using a standard dye uptake
method (Nath et al., 2014). Briefly, thawed SSMs were plated
in Krebs-like physiological buffer (KPB: 143 mM NaCl, 4.7 mM
KCl, 1.3 mM MgSO4, 1.2 mM CaCl2, 20 mM HEPES,
1http://statistica.mooo.com
0.1 mM NaH2PO4, 10 mM glucose; pH 7.4) and depolarized
for 2 min at 30◦C using 40 mM K+ in the presence of
1 µM FM4-64 (Invitrogen). SSMs were washed with KPB
supplemented with 1 mM Advasep-7 (Sigma–Aldrich) prior to
mounting in DAKO mounting medium (DAKO) for fluorescence
imaging.
Microscopy
Imaging was carried out on a Zeiss Axioplan2 with a 63×, 1.4 NA
objective.
Ethics Statement
Only chick embryos were used in this study. The University
Health Network TG&W Animal Care Committee has granted
a waiver to perform these experiments as the embryos
used in this study were all in early stages of embryonic
development and before day 21 and therefore committee review
and approval was not necessary. However, the study was
reviewed by a veterinarian and the euthanasia procedure was
validated.
Peptide Mimetic Blocker Experimental
Design and Analysis
The experiment and data analysis were carried out blind.
A laboratory member unconnected with the SV recycling
experiment assigned an alphabet code to each test peptide
and the code was broken on completion of analysis. The
styryl dye uptake quantification method has been described
(Nath et al., 2014). Briefly, a minimum of three images
per treatment per experimental trial were quantified.
Cryoloaded single SSMs were identified by positive stain
for the loading marker (FITC-dextran) and were imaged by
bright field to ensure isolation from un-loaded neighbors.
Each FITC-stained SSM was scored as FM4-64 positive
or negative by eye and the ratio of positive over total
examined was used to calculate the percentage of SV recycling
SSMs.
The fraction of dextran-positive control SSMs that showed
styryl dye uptake was consistent between experimental trials
and across treatments (no-load, 61.3 ± 3.2; HEADEDDWC
59.5± 1.6) and hence, normalization was not necessary. Student’s
t-test was used to compare test peptide-treated to both the No-
load and HEADEDDWC peptide controls.
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FIGURE 2 | (A) Effect of the mimetic blocking peptides on SV-PD with C3WildF. Purified SVs were pre-treated with each of the five mimetic blocking peptides or
HEADE and SH3 controls (0.6 mM) prior to SV-PD with C3WildF fusion protein. SV-PD was assessed by the vesicle marker proteins, SV2 and STG. We also blotted
for two additional integral proteins, V-ATPase and VAMP. Compared to the SH3 peptide control, integral SV protein band intensities were reduced by HQARRVPNGY
and GTGTRGRSYY, increased by HEADE and minimally affected by ATNSGRSSRT, SYVSSLTSQS, or HYTLGLNTGP. Protein bands were faint with a purified GST
control. C3WildF fusion protein was identified by either anti-FLAG or anti-CaV2.2 (L4569) antibodies. (B) Quantification of mimetic peptide effect on SV-PD. SV2 and
STG protein band intensities were normalized to the SH3 control peptide on the same immunoblot. Column graphs of SV2 (top) and STG (bottom) show percent
mean ± SE of N separate experiments. HQARRVPNGY (N = 8) and GTGTRGRSYY (N = 5) peptides inhibited SV capture as indicated by both vesicle marker
proteins (SV2, top; STG, bottom). SYVSSLTSQS shows a large variability between experiments due to a single outlier; if omitted the mean was 118 ± 35%. HEADE
peptide resulted in a significant enhancement in the mean SV2 band intensity (SYVSSLTSQS N = 5; HEADE, N = 6). t-test, ∗p < 0.05; ∗∗p < 0.01, ∗∗∗p < 0.001.
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FIGURE 3 | HQARRVPNGY inhibits SV-PD with native C3 fusion protein. (A) The effect of HQARRVPNGY on SV capture as in Figure 2 was repeated using
C3GST probing for SV2 and STG (0.6 mM peptide). (B) The peptide inhibited SV-PD compared to SH3 peptide whereas three control peptides, a zero peptide
control and also one other test peptide, HYTLGLNTGP, had no effect. Both SV2 and STG exhibited increased mean band intensities with HEADE but this did not
reach statistical significance (t-test, p > 0.1) while HEADEDDWC was unchanged. ∗p < 0.05, ∗∗p < 0.01.
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RESULTS
SV Binding Assay, Bait Proteins, and
C-terminal Mimetic Blocking Peptides
The SV-PD Assay
We have described a cell-free assay, termed SV-PD, to test if
SVs can be captured by the intact CaV2.2 channel. Briefly, fresh
SVs are purified by differential centrifugation on discontinuous
sucrose gradients for each experiment. The SVs are then
incubated with an immobilized bait, in the present case the distal
third of the channel C-terminal (C3 region), in a detergent-free
buffer. Successful SV capture is assessed by Western blot for
integral SV proteins (SV2, STG, VAMP, etc).
CaV2.2 distal C-terminal Fusion Proteins
Most of these experiments were carried out using the N-terminal-
GST-tagged fusion protein, C3wildF (Figure 1A), as the bait.
C3wildF fusion protein is identical to the chick C-terminal C3
region except for the addition of a FLAG tag to the C-terminal
tip (Wong et al., 2014) and was used for most of this study.
We also generated a new fusion protein, C3GST (Figure 1A, see
below) which is identical to the native C-terminal but differs from
C3wildF by the absence of the FLAG tag. Both fusion proteins were
purified with high yield by our bacterial expression system and
were robust for SV-PD.
Blocking Peptides
To further restrict the SV attachment site within the
previously identified 49 aa region of the C3 terminal region
we synthesized five abutting 10 aa mimetic blocking peptides
(Figure 1A). Beginning from the N terminal end these were:
ATNSGRSSRT, SYVSSLTSQS, HQARRVPNGY, HYTLGLNTGP,
and GTGTRGRSYY. The peptide blockers were designed to
be non-overlapping to permit their use in combinations while
minimizing complication due to mutual binding interference.
Effect of Single Mimetic Peptides on SV-PD
A subset of the SV binding region mimetic peptides inhibited
SV-PD
To identify which segment of the SV binding region plays a
role in SV binding we carried out SV-PD experiments in the
presence of each of the five peptides separately (Figure 2A). SV2
and STG bands were quantified by densitometry (Figure 2B) and
normalized to a control SH3 peptide-treated band.
The results with SV2 and STG were comparable but the
immunoblot signal-to-noise ratio was higher with the former.
The blots showed that SV-PD was not significantly inhibited by
ATNSGRSSRT, SYVSSLTSQS (which exhibited large variability),
or HYTLGLNTGP. However, it was reduced significantly by
HQARRVPNGY (p < 0.001) and by GTGTRGRSYY (p < 0.01;
Figure 2B).
HQARRVPNGY Inhibits SV Capture with Native C3
Fusion Protein
The fusion protein used in the above studies, C3WildF is identical
to the native, long splice chick CaV2.2 aa sequence but with
a FLAG tag on its terminus. To increase confidence in our
results and to rule out the remote possibility that the FLAG
tag introduced anomalous results we repeated the experiment
with C3GST which lacks this tag. This fusion protein also
captured SVs, as assessed by SV-PD (Figure 3A) and, consistent
with the findings with C3WildF, this was markedly inhibited by
HQARRVPNGY but not by another binding region peptide,
HYTLGLNTGP, as compared to no-peptide or SH3 (Figure 3B).
Compared to the no-peptide or SH3 controls, the mean SV-
PD was higher with HEADE and HYTLGLNTGP, but neither
reached significance (p > 0.1 for both SV2 and STG). No
significant effect was observed with the HEADEDDWC control
peptide (p> 0.1).
SV Recycling Is Inhibited by Single Peptides
We used cryoloading/styrlyl dye uptake (Nath et al., 2014) to
test if the effect observed in the cell-free SV-PD assay predicts
the effect of the peptide blockers on SV recycling in intact
synaptosomes. Test and control peptides were cryoloaded into
the SSMs together with an inert fluorescent dextran marker. The
fraction of individual dextran-positive SSMs that recycled SVs
was assayed by styryl dye uptake (Figure 4A), as described (Nath
et al., 2014; Wong et al., 2014). A blinded protocol was used:
the investigator carrying out the peptide loading and imaging
was unaware of the treatments until after each experiment was
completed and analyzed.
Styryl dye uptake was indistinguishable between the dextran-
only controls and with the control peptide HEADEDDWC
and also several of the test peptides, including ATNSGRSSRT,
SYVSSLTSQS, and GTGTRGRSYY. A significant, but moderate
reduction was observed with HYTLGLNTGP (p < 0.02).
However, HQARRVPNGY caused a marked, ∼55% reduction
(compared to untreated control) in dye-positive SSMs (p< 0.001;
Figure 4B).
Peptide Combinations
We carried out a number of pilot experiments to test if SV-PD
or styryl dye uptake could be further inhibited using various
combination of the five mimetic peptides. However, since none
of the combinations tested resulted in qualitatively greater effect
than with the HQARRVPNGY peptide alone we presume that the
primary SV binding site is within this 10 aa stretch.
Peptide Blockers and the Capture of the SV
Accessory Protein RIM1/2
The effect of the peptide blockers and controls on SV-PD was
generally consistent regardless of which SV integral membrane
protein was used as the SV capture indicator. There has been
considerable interest in the role of RIM1/2 in SV recruitment
and hence, we also blotted for this protein in our SV-PD
experiments. As reported previously (Wong and Stanley, 2010),
RIM1/2 protein bands detected by Western blot of the SVs
were typically not intense (Figure 5A). Interestingly, the mimetic
peptide generated a different pattern of RIM1/2 recovery than
for the integral SV proteins, as detailed above. Using C3WildF
as the bait protein, RIM1/2 was detected in the presence of all
test or control peptides (Figure 5A). Densitometry analysis of
two high-molecular weight bands in the RIM ladder (1 and 2 in
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FIGURE 4 | Effect of mimetic peptides on SV recycling. SSMs were cryoloaded in a blinded manner with the indicated peptides (1.2 mM) together with 3 kD
Dextran-FITC (20 µM). The cryoloaded terminals were depolarized with 40 mM K+ in the presence of 1.2 mM Ca2+ to trigger exocytosis and uptake of FM4-64
(1 µM) by vesicle turnover. The FITC panels show SSMs that have been cryoloaded with the loading marker and the FM4-64 panels show SSMs that have taken up
styryl dye. Blue circles indicate SSMs that are peptide loaded, as indicated by the loading marker, and are also positive for FM4-64. Green circles indicate SSMs
that have been cryoloaded but fail to take up FM4-64. The red circle indicates an SSM that was not cryoloaded but was able to take up FM4-64. (B) Histogram of
percent ± SE of dextran-positive SSMs that were FM4-64 positive from four experiments. Statistical test to the dextran-only control and HEADEDDWC, respectively,
for each treatment are indicated as: t-test, ∗p < 0.05, ∗∗p < 0.01. Analysis by ANOVA (Bonferroni–Holm) confirmed a reduction in dye-uptake with HQARRVPNGY
(p << 0.01).
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FIGURE 5 | Synaptic vesicle accessory protein RIM1/2 recovery is not blocked by HQARRVPNGY. (A) As in Figure 3, purified SVs were treated with
blocking or control peptides (0.6 mM each) followed by SV-PD with C3WildF. SH3 peptide was used as a control. As above, HQARRVPNGY markedly inhibited SV
capture compared to controls as indicated in the SV2 immunoblot. GST + SH3 control lane shows protein capture in the absence of the C3-FLAG protein.
(B) Mean + SE RIM1/2 higher (band #1, upper histogram) and lower (band #2, lower histogram) molecular weight band intensities were normalized to the SH3
control from the same experiment and plotted and were analyzed as in Figure 2. HQARRVPNGY had no significant effect on RIM1/2 capture as assessed by protein
band intensity 1 or 2 (as labeled). Lower mean RIM1/2 intensities were observed with GTGTRGRSYY for both quantified bands but this failed to reach statistical
significance (t-test, 0.1 > p > 0.05).
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Figure 5A) failed to demonstrate inhibition by HQARRVPNGY
(Figure 5B). The mean intensity was lower in the presence
of GTGTRGRSYY peptide but this failed to reach statistical
significance (0.1 > p > 0.05). The C3GST fusion protein
(Figure 1A), that lacks the distal FLAG tag and is identical to the
native protein gave very similar results (data not shown).
The HQARRVPNGY Region is Necessary for Effective
SV Capture by the C3 Region
The peptide block experiments above identify the
HQARRVPNGY region as containing the binding site for
the SV onto the distal C-terminal. To rule out the possibility
that the peptide might interfere with SV-PD by an anomalous
mechanism we created a new GST fusion protein, C3HQless,
that was identical to C3WildF which lacks HQARRVPNGY
(Figure 6A). Western blots of the C3HQless fusion protein probed
with FLAG (not shown) or anti-CaV2.2 C-terminal tip (L4569)
antibody exhibited bands with a molecular weight that was, as
expected, slightly lower than for C3WildF (Figure 6B). SV-PD
was markedly reduced (N = 3) using C3HQless as the bait in
comparison with C3WildF (Figure 6B), providing independent
support for the conclusion that HQARRVPNGY contains a key
C3 region SV binding aa sequence. This region is the focus of
the rest of this study though the residual SV-PD may indicate
a secondary binding site. Further studies will be necessary to
determine if there is any significant residual SV binding by the
rest of the C3 region.
Identification of the HQARRVPNGY Binding Motif:
Bioinformatics Analysis
Alignment of chick, rat and human CaV2.2 C-terminal sequences
identified the conserved aa residues HxxRRVPNGY (Figure 7A),
or HxxRR8PNGY, where 8 is a hydrophobic residue. Since
CaV2.1 channels are also important for transmitter release at fast
transmitting terminals we extended the analysis to this channel
type (note: chick CaV2.1 has not been cloned). This reduced
the highly conserved region to RR8PNGY, and served as our
candidate binding motif.
FIGURE 6 | Deletion of HQARRVPNGY from the C-terminal C3 region greatly reduces SV capture. (A) A GST-tagged C3 fusion protein, C3HQless, was
generated that was identical to C3WildF but without the HQARRVPNGY sequence. (B) The molecular weight of the GST-C3HQless band was confirmed by
identification in a Western blot by both anti-GST (on the N terminal end, data not shown) and L4569, the antibody directed against the distal tip of the CaV2.2
C-terminal (beyond the deleted region). SV-PD was markedly reduced with C3HQless compared to C3WildF. In the blot shown the concentration of C3HQless was equal
or higher than that of C3WildF, as demonstrated in a two-step method. First, we used L4569 to identify the protein band corresponding to each fusion protein. Since
these bands were saturated in the blot, even with very short exposures, they could not be used for quantification. However, we also identified protein bands using a
‘Stain-free’ method and these bands were not saturated. Based on the L4569 probe we quantified the fusion protein bands by densitometry to obtain a
C3WildF/C3HQless ratio of 0.81. Thus, the SV2 bands were far darker with C3WildF despite a lower concentration of the fusion protein. Similar results were observed in
two additional experiments.
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FIGURE 7 | The HQARRVPNGY peptide region is conserved across fast-transmission presynaptic calcium channel types. Each panel shows an
alignment of the chick CaV2.2 distal C3 region, as examined in this study, with the indicated CaV channel types from chick, rat, and human (as available). (A) CaV2.1
and CaV2.2. The five mimetic peptides (corresponding to chick CaV2.2) are indicated under the alignment. (B) CaV2.3. (C) CaV1.3. (D) CaV1.4. The HQARRVPNGY
peptide sequence is indicated by the dashed box in each panel. ∗Distal aa extends beyond the diagram. Numbers above each set reflect the aligned protein set
(including gaps), and do not correspond to any individual channel type.
Identification of the HQARRVPNGY Binding Motif:
Blocking Peptide Analysis
To gain further insight into the SV binding site we
created an additional series of blocking peptides in which
amino acid residues of interest were mutated and tested
with SV-PD (Figures 8A–C). SH3 or zero peptide, and
HQARRVPNGY itself were used as negative and positive
controls, respectively. Analysis focused on SV2 recovery
but across the experiment STG recovery correlated strongly
(r = 0.977, p<< 0.01)
Substitution of the two hydrophobic aa (8), V and
Y, with A or G (HQARRAPNGA, HQARRGPNGG;
Figures 8A–C) had no effect on block. Interestingly, and
to our surprise, neither did substitution of the entire
highly conserved 8PNGY sequence HQARRAGGGA and
HQARRGAAAG (Figures 8B,C). This result contradicted our
bioinformatics-based hypothetical 8PNGY-based SV-binding
motif. We therefore turned our attention to the first five aa
of HQARRVPNGY. Mutation of the arginine pair with either
A or G (HQAAAVPNGY, HQAGGAGGGA; Figures 8A–
C) eliminated inhibition of SV-PD, suggesting that these
are essential. However, this aa pair was not sufficient for
the full effect, because SV-PD inhibition was also reduced
by replacement of the first two aa, HQ (AAARRVPNGY,
GGARRAGGGA; Figures 8A–C). Without HQ the mean
SV2 recovery was significantly less than 100% with both
peptides, based on a t-test analysis but significance was
not reached using ANOVA. Thus, our data is at least
suggestive that the RR pair can cause a partial inhibition
of SV-PD. In summary, our analysis identified the RR
aa pair as essential for SV capture and this was enhanced
by HQ.
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FIGURE 8 | Blocking peptide analysis of the SV binding motif. (A) and (B) SV-PD assessed by immunoblot for SV integral membrane proteins in the presence
of a range of HQARRVPNGY mutant peptides. SH3 and HQARRVPNGY served as negative and positive controls, respectively. (C). SV2 bands densitometry
histograms normalized to SH3. N = number of separate experiments. Values are means ± SE. Means were tested for significance from 100%: t-test, ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001. The data was also analyzed using by post hoc ANOVA, correcting for multiple comparisons (Bonferroni and Holm). The significance levels
were similar: 0 peptide p > 0.05; HQARRVPNGY p < 0.01, HQARRAPNGA p < 0.01, HQARRGPNGG p < 0.05, AAARRVPNGY p > 0.05, GGARRAGGGA
p > 0.05, HQARRAGGGA p < 0.05, HQARRGAAAG p < 0.01, HQARRAAAAA p < 0.05, HQAAAVPNGY p > 0.05, and HQAGGAGGGA p > 0.05. Note, however,
that SV2 capture with AARRVPNGY and GGARRAGGGA peptides was reduced significantly with the t-test but not the ANOVA analysis.
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DISCUSSION
The objective of this study was to identify an SV binding
site within a 49 aa region of the distal C-terminal as
reported earlier (Wong et al., 2014). We report first, that
a 10 aa peptide, HQARRVPNGY, markedly inhibited
SV capture using two different distal C3 region fusion
proteins and also inhibited SV recycling, as assessed by
depolarization-triggered styryl dye uptake. Within the
HQARRVPNGY sequence we find that the HxxRR motif
is required for effective SV capture by the channel C3
region.
Most of the experimental techniques and materials used in
this study have been validated previously including fractionation,
purification and characterization of SSMs and SVs (Juhaszova
et al., 2000; Wong et al., 2013, 2014]; the SV-PD assay
(Wong et al., 2013) and the peptide-cryoloading method
combined with styryl dye assessment of SV recycling (Nath
et al., 2014). Three fusion proteins were used. C3WildF was
reported previously (Wong et al., 2014) while C3GST, a
new bait that lacks the terminal FLAG tag, is identical
to the previously reported C3Strep (Wong et al., 2014)
but is tagged with GST to make it comparable with our
other constructs. We also constructed C3HQless, which is
identical to C3WildF but with an excised HQARRVPNGY
region.
In a previous study we reported that the distal tip peptide
HEADEDDWC or its proximal segment, HEADE, did not
inhibit SV-PD. We therefore assumed that we could use
HEADE as a peptide control. To our surprise this peptide
increased SV-PD, as confirmed by comparison to the SH3
peptide [that also did not inhibit SV-PD previously (Wong
et al., 2014)] as well as all the inactive peptides used
in this study (Figures 2B, 3B, and 8). This result might
indicate that there is a region in the C-terminal that acts
as an ‘on’-switch for binding. However, the failure to detect
a similar enhancement with the overlapping, but longer
HEADEDDWC peptide raises a question as to whether this
has biological significance and will be explored in a future
study.
Out of the five mimetic blocking peptides spanning the 49
aa binding site only HQARRVPNGY reliably and effectively
inhibited SV-PD. A smaller effect was, however, also observed
with GTGTRGRSYY. Of these two, only the former showed
FIGURE 9 | Evolutionary conservation of the SV binding motif in early
vertebrates. Alignment of the region encompassing the chick CaV2.2
HQARR sequence for species from chick (yellow highlight) to fish. Positively
charged aa are indicated in red. #Sequence predicted by GenBank software
but not cloned.
evidence of functional inhibition of SV recycling, supporting the
hypothesis that this binding site has biological significance. We
have not explored the role of GTGTRGRSYY further but the lack
of functional inhibition with this peptide in the synaptosome
cryoloading experiments combined with the marked reduction
in SV-PD observed with C3HQless, which retains GTGTRGRSYY,
suggests that its role is of less significance than that of the
HQARRVPNGY region. A moderate reduction in styryl dye
uptake was also observed with HYTLGLNTGP. Since this
peptide had no detectable effect on SV-PD, we suppose that it
interferes with an unrelated molecular interaction during SV
recycling.
We used the SV-PD/peptide block strategy to carry
out a systematic analysis of the binding site aa sequence
(Figure 8). To our surprise, the ∗PNGY region could be
mutated without any obvious loss of SV capture. However,
removal of the arginine pair eliminated SV-PD. Interestingly,
inhibition of SV-PD by the RR pair was markedly reduced,
but not eliminated if HQ was also mutated. Since HQ
could not capture SVs in the absence of the arginine
pair we conclude that it plays a facilitatory role in SV
binding.
The HxxRR motif is conserved in CaV2.2 channels from
chick to human, consistent with a significant biological role
(Figure 7A) and the RR pair can be traced at least as
far back as to fish (Figure 9). Interestingly, in the other
principal release site-associated calcium channel, CaV2.1, the
arginine pair is retained but the Hxx is replaced with an
RHxRR (Figure 7A) in which the positive charge is not
only retained but enhanced and may serve the same binding
function.
Alignment of CaV2.3 channels, which can also support
transmitter release at fast synapses, with CaV2.2 failed
to identify any of the HxxRR elements (Figure 7B),
raising a question as to how these channels may bind SVs.
However, further scrutiny reveals a downstream H#RRRR(R)
(Figure 7B) which might serve the same function. The more
distantly related CaV1.3/CaV1.4, which gate transmitter
release at sensory cell synapses (Vigh and Lasater, 2004;
Brandt et al., 2005; Cho and von, 2012), such as at the
higher vertebrate auditory hair cell, lack the HxxRR motif
(Figures 7C,D). The motif is also absent in Drosophila
CaV2.2-like channels (data not shown). Interestingly, both
the sensory cell and Drosophila synapses exhibit a release
site-associated structure, a ribbon in the former and T-bar
in the latter, that is absent from fast transmitting synapses.
Perhaps these structures usurp the SV binding site on the
C-terminal. It is possible, therefore, that the SV binding
site is specific for SV recycling at classical, fast transmitting
release sites and that it evolved at an earlier stage during
the diversification of CaV2 types (Anderson and Greenberg,
2001).
As expected, since they are all components of the same
SVs, integral SV proteins were recovered in parallel in SV-PD
experiments – thus, enhancement or inhibition of one such
protein was mirrored by an equal enhancement or inhibition
of its partner integral protein (Wong et al., 2014). However,
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immunoblot bands for the SV-associated protein RIM1/2
were faint and did not vary in parallel with the integral
proteins (Figure 5). Thus, RIM1/2 capture was not reduced
significantly by HQARRVPNGY nor was it enhanced by HEADE,
supporting the hypothesis that RIM1/2 interacts with the
channel C3 region by a mechanism that somehow differs
from that with the integral SV proteins (Wong et al., 2014).
A number of previous reports have failed to demonstrate
RIM1/2 co-immunoprecipitation with the full-length CaV2.2
(Hibino et al., 2002; Khanna et al., 2006; Wong and Stanley,
2010), arguing against a common stable complex. However, co-
variance of the channel and RIM1/2 at the intact transmitter
release site does support the idea that the two proteins
are components of separate interacting molecular complexes
(Khanna et al., 2006). How RIM1/2 can be isolated with the
purified SVs and yet fail to act in accord with the other SV
proteins remains a mystery that will be the subject of further
study.
This study does not address at which stage the C-terminal
HxxRR contributes to SV recycling nor does it identify its
putative SV binding partner. The length of the C-terminal
and lack of predicted structure make it less attractive as
a mechanism to bring the SV within range of the CaV
calcium nanodomain (Wong et al., 2014; Stanley, 2015), at
least without additional molecular partners. We have recently
speculated that this binding region may play a role in delivering
the SV to the release site, serving to capture the vesicle
from the surrounding cytoplasm (Wong et al., 2014; Stanley,
2015) while additional and subsequent molecular interactions
determine the precise molecular arrangement required for
nanodomain-based release gating (Weber et al., 2010; Wong
et al., 2014).
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